Posted on September 4th, 2009 by Health News
A third of the previously identified single-nucleotide polymorphisms, or SNPs, associated with prostate cancer in men of European or African ancestry were also associated with prostate cancer in a Japanese population, according to a new study published online September 2 in the Journal of the National Cancer Institute.
Read more
Filed under: Men's Health
Tags: cancer, Men's Health, Online, Prostate Cancer
Related posts
- The Relationship Between Age At Time Of Surgery And Risk Of Biochemical Failure After Radical Prostatectomy (0)
UroToday.com - In the online edition of the British Journal of Urology International, a group from Columbia University Department of Urology report that older men undergoing radical prostatectomy (RP) for prostate cancer (CaP) do not have an increased risk of disease recurrence in the multivariate context that includes PSA level, Gleason score and clinical stage...
Read [...]
- Sodium Clodronate Improves Survival In Patients With Advanced Prostate Cancer But Not With Localised Disease (0)
An article published Online First and in an upcoming edition of The Lancet Oncology reports that oral sodium clodronate improves overall survival in men with advanced prostate cancer. However it does not reduce the risk of death in men with localised disease. These are the final results of the MRC PR05 and MRC PR04 trials. [...]
- Scientists Identify Three New Genetic Variants That Increase Testicular Cancer Risk (0)
A study led by The Institute of Cancer Research (ICR) has identified three new genetic risk factors for testicular cancer. The findings, published online today in Nature Genetics, come during the Everyman Male Cancer Awareness Month , which aims to increase awareness and funding for vital research into testicular and prostate cancers...
Read more
[tags] Men's Health [...]
- Reducing Hot Flushes In Men Undergoing Hormone Therapy For Prostate Cancer: Medroxyprogesterone Seems To Be The Best Treatment (0)
An article published Online First and in The Lancet Oncology reports that the hormonal treatments cyproterone acetate and medroxyprogesterone acetate are the most efficient at reducing hot flushes. This is a common side-effect in men being treated with hormone therapy for prostate cancer...
Read more
[tags] Men's Health [/tags]
- PSA Screening Cuts Deaths By 20%, Says World’s Largest Prostate Cancer Study (0)
Screening for prostate cancer can reduce deaths by 20%, according to the results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) published online 1700 hours CET 18 March (NEJM, Online First). ERSPC is the world's largest prostate cancer screening study and provides robust, independently- audited evidence, for the first time, of the [...]
Leave a Reply